|
Originally published In Press as doi:10.1074/jbc.M107919200 on October 9, 2001
J. Biol. Chem., Vol. 276, Issue 51, 48118-48126, December 21, 2001
Potent Inhibition of NFAT Activation and T Cell Cytokine
Production by Novel Low Molecular Weight Pyrazole Compounds*
James M.
Trevillyan ,
X. Grace
Chiou,
Yung-Wu
Chen,
Stephen J.
Ballaron,
Michael P.
Sheets,
Morey L.
Smith,
Paul E.
Wiedeman,
Usha
Warrior,
Julie
Wilkins,
Earl J.
Gubbins,
Gerard D.
Gagne,
Jane
Fagerland,
George W.
Carter,
Jay R.
Luly,
Karl W.
Mollison, and
Stevan W.
Djuric
From the Global Pharmaceutical Products Division, Abbott
Laboratories, Abbott Park, Illinois 60064
NFAT (nuclear
factor of activated T cell)
proteins are expressed in most immune system cells and regulate the
transcription of cytokine genes critical for the immune response. The
activity of NFAT proteins is tightly regulated by the
Ca2+/calmodulin-dependent protein
phosphatase 2B/calcineurin (CaN). Dephosphorylation of NFAT by CaN is
required for NFAT nuclear localization. Current immunosuppressive drugs
such as cyclosporin A and FK506 block CaN activity thus
inhibiting nuclear translocation of NFAT and consequent cytokine gene
transcription. The inhibition of CaN in cells outside of the immune
system may contribute to the toxicities associated with cyclosporin A
therapy. In a search for safer immunosuppressive drugs, we identified a
series of 3,5-bistrifluoromethyl pyrazole (BTP) derivatives that block
Th1 and Th2 cytokine gene transcription. The BTP compounds block the
activation-dependent nuclear localization of NFAT as
determined by electrophoretic mobility shift assays. Confocal
microscopy of cells expressing fluorescent-tagged NFAT confirmed that
the BTP compounds block calcium-induced movement of NFAT from the
cytosol to the nucleus. Inhibition of NFAT was selective because the
BTP compounds did not affect the activation of NF- B and AP-1
transcription factors. Treatment of intact T cells with the BTP
compounds prior to calcium ionophore-induced activation of CaN caused
NFAT to remain in a highly phosphorylated state. However, the BTP
compounds did not directly inhibit the dephosphorylation of NFAT by CaN
in vitro, nor did the drugs block the dephosphorylation of
other CaN substrates including the type II regulatory subunit of
protein kinase A and the transcription factor Elk-1. The data suggest
that the BTP compounds cause NFAT to be maintained in the cytosol in a
phosphorylated state and block the nuclear import of NFAT and, hence,
NFAT-dependent cytokine gene transcription by a mechanism
other than direct inhibition of CaN phosphatase activity. The
novel inhibitors described herein will be useful in better defining the
cellular regulation of NFAT activation and may lead to identification
of new therapeutic targets for the treatment of autoimmune disease and
transplant rejection.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: D-47R, AP10-103, 100 Abbott Park Rd., Abbott Park, IL 60064. Fax: 847-938-1674; E-mail:
james.m.trevillyan@abbott.com.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
U. Niesner, I. Albrecht, M. Janke, C. Doebis, C. Loddenkemper, M. H. Lexberg, K. Eulenburg, S. Kreher, J. Koeck, R. Baumgrass, et al.
Autoregulation of Th1-mediated inflammation by twist1
J. Exp. Med.,
August 4, 2008;
205(8):
1889 - 1901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. I. Jabr, A. J. Wilson, M. H. Riddervold, A. H. Jenkins, B. A. Perrino, and L. H. Clapp
Nuclear translocation of calcineurin Abeta but not calcineurin A{alpha} by platelet-derived growth factor in rat aortic smooth muscle
Am J Physiol Cell Physiol,
June 1, 2007;
292(6):
C2213 - C2225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Steinckwich, J.-P. Frippiat, M.-J. Stasia, M. Erard, R. Boxio, C. Tankosic, I. Doignon, and O. Nusse
Potent inhibition of store-operated Ca2+ influx and superoxide production in HL60 cells and polymorphonuclear neutrophils by the pyrazole derivative BTP2
J. Leukoc. Biol.,
April 1, 2007;
81(4):
1054 - 1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Nilsson, Z.-W. Sun, J. Nilsson, I. Nordstrom, Y.-W. Chen, J. D. Molkentin, D. Wide-Swensson, P. Hellstrand, M.-L. Lydrup, and M. F. Gomez
Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation
Am J Physiol Cell Physiol,
March 1, 2007;
292(3):
C1167 - C1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. W. Bush, D. B. Hood, P. J. Papst, J. A. Chapo, W. Minobe, M. R. Bristow, E. N. Olson, and T. A. McKinsey
Canonical Transient Receptor Potential Channels Promote Cardiomyocyte Hypertrophy through Activation of Calcineurin Signaling
J. Biol. Chem.,
November 3, 2006;
281(44):
33487 - 33496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Nilsson, L. M. Nilsson, Y.-W. Chen, J. D. Molkentin, D. Erlinge, and M. F. Gomez
High Glucose Activates Nuclear Factor of Activated T Cells in Native Vascular Smooth Muscle
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2006;
26(4):
794 - 800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Takezawa, H. Cheng, A. Beck, J. Ishikawa, P. Launay, H. Kubota, J.-P. Kinet, A. Fleig, T. Yamada, and R. Penner
A Pyrazole Derivative Potently Inhibits Lymphocyte Ca2+ Influx and Cytokine Production by Facilitating Transient Receptor Potential Melastatin 4 Channel Activity
Mol. Pharmacol.,
April 1, 2006;
69(4):
1413 - 1420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-R. T. Motameni, I. J. Juncadella, S. K. Ananthanarayanan, M. N. Hedrick, Y. Huet-Hudson, and J. Anguita
Delivery of the Immunosuppressive Antigen Salp15 to Antigen-Presenting Cells by Salmonella enterica Serovar Typhimurium aroA Mutants
Infect. Immun.,
June 1, 2004;
72(6):
3638 - 3642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Zitt, B. Strauss, E. C. Schwarz, N. Spaeth, G. Rast, A. Hatzelmann, and M. Hoth
Potent Inhibition of Ca2+ Release-activated Ca2+ Channels and T-lymphocyte Activation by the Pyrazole Derivative BTP2
J. Biol. Chem.,
March 26, 2004;
279(13):
12427 - 12437.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|